湖北华博医药科技有限公司

Hubei Huabo Pharmatech Co., Ltd.

        湖北华博医药科技有限公司成立于2022年3月7日，位于湖北省应城市长江埠赛孚科技工业园区（省级园区），厂区占地面积130亩，总投资3亿元人民币，从事利巴韦林， 列汀类，他汀类，沙坦类等医药中间体及原料药生产的专业化企业。于2023年被列入应城市重点招商引资项目，得到了国家政策的鼓励和当地政府大力支持。公司主要管理团体来自浙江的医药上市公司。 华博医药于2022年9月控股收购了湖北志诚化工科技股份有限公司， 湖北志诚成立于2002年11月19日，是“国家高新技术企业”，2018年度因产品甲酯被评为“省级隐形冠军企业”，2019年度因产品甲酯被评为“省级科技小巨人企业”。中国精细化工行业甲酯产品领军企业，通过了ISO9001质量体系认证。
        公司主营业务是医药中间体的研发、生产和销售。同国内外知名的医药公司有着长期稳定的业务。同时致力于打造高端原料的CRO/CMC的制造服务平台。公司通过专业化高标准的工艺研究、质量管理和项目管理体系，专注于高技术壁垒、高难度、复杂手性药物原料药和中间体产品的研发生产，产品涵盖抗病毒、抗肿瘤、糖尿病、心脑血管疾病等领域。目前已完成工艺研发并延伸为原料药及中间体的产品超过20种，其中10个产品已具备产业化基础。产品销售国内外市场，公司宗旨是始终致力于打造客户满意、员工满意、社会认可的有责任有担当的一流医药企业。

        Huabo Pharma was established on March 7, 2022. It is located in Saifu Industrial Park of Changjiangbu, Yingcheng, Hubei, （a provincial-level chemical Area）.

        Huabo Pharma covers land area of 90000 square meters with planned total investment 300 million RMB, and it is specialized in production of APIs and intermediates including Ribavirin , Gliptins series, Tatins series and Sartans series etc.   Huahbo Pharma was generously supported by local government and listed as Yingcheng key investment promotion project in 2023. Huabo’s main management team are from Zhejiang listed big pharmaceutical companies.  

        Huabo Pharma acquired Hubei Zhicheng Chemical Co., Ltd in Sep 2022.   Hubei Zhicheng Chemical was established on 19 Nov 2002 and was credited as High-Tech enterprise. Hubei Zhicheng is the largest manufacturer of 1H-1,2,4-Triazole-5-carboxylic acid methyl ester in China and Zhicheng Chem has obtained certification of ISO 9001 and was credited as Provincial “Little Giant" firm in 2019.

        Hubei Huabo Pharma and Hubei Zhicheng Chem have established long term stable business with some famous pharmaceutical companies home and abroad.

        Our core value: Quality, Innovation, reliability and sustainability

        Our business concept:  Customer centric and Market driven.